TR
Insider
Thomas Andrew Rowland
SVP, HEAD - ESTABLISHED BRANDSThomas Andrew Rowland (SVP, HEAD - ESTABLISHED BRANDS) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $357K of ANIP (4,772 sh × $74.91, as filed), executed Mar 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$357K
shares × price, as filed
Last traded
Mar 11
Filed Mar 13
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $784K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$357K4,772 sh × $74.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $426K
4,975 sh × $85.71
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET